Although the aforementioned studies demonstrate that the role of TRPV2 in cancer progression is unclear, research that examined the impact of cannabinoids on this cation channel demonstrated that TRPV2 activation decreased tumor cell survival and sensitized tumor cells to clinically available chemotherapeutic agents. Here, TRPV2 is linked to cancer.